Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 17, 2022

SELL
$27.59 - $66.39 $203,917 - $490,688
-7,391 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$65.76 - $90.65 $486,032 - $669,994
7,391 New
7,391 $486,000
Q3 2020

Dec 11, 2020

SELL
$43.0 - $84.01 $182,105 - $355,782
-4,235 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$51.3 - $75.21 $217,255 - $318,514
4,235 New
4,235 $309,000

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $275M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.